Aerovate Therapeutics, Inc.

NasdaqGM:AVTE Stock Report

Market Cap: US$76.8m

Aerovate Therapeutics, Inc. Company Information

Aerovate Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Aerovate Therapeutics, Inc.
  • Ticker: AVTE
  • Exchange: NasdaqGM
  • Founded: 2018
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$76.806m
  • Shares Outstanding: 28.87m
  • Website: https://aerovatetx.com

Number of Employees


Location

  • Aerovate Therapeutics, Inc.
  • 930 Winter Street
  • Suite M-500
  • Waltham
  • Massachusetts
  • 02451
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AVTENasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDJun 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/25 11:43
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.